Kirsten Harting

Kirsten Harting

Chief Tech/Sci/R&D Officer at SYNACT PHARMA AB
Health Technology
Consumer Services
Commercial Services

Profile

Kirsten Harting currently works at SynAct Pharma AB, as Chief Medical Officer from 2024 and Tetra Pharm Technologies ApS, as Chief Medical Officer.
Dr. Harting also formerly worked at CytoKi Pharma ApS, as Senior Director-Medical, Alzinova AB, as Chief Medical Officer from 2023 to 2025, and Sandoz Group AG, as Chief Medical Officer.
Dr. Harting received her Masters Business Admin degree from Copenhagen Business School and doctorate degree from the University of Copenhagen.

Kirsten Harting active positions

CompaniesPositionStart
SYNACT PHARMA AB Chief Tech/Sci/R&D Officer 15/02/2024
Chief Tech/Sci/R&D Officer -

Former positions of Kirsten Harting

CompaniesPositionEnd
ALZINOVA AB Chief Tech/Sci/R&D Officer 28/01/2025
SANDOZ GROUP AG Chief Tech/Sci/R&D Officer -
Chief Tech/Sci/R&D Officer -
See the detail of Kirsten Harting's experience

Training of Kirsten Harting

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

2

1st degree connections

7

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies7

Consumer Services

Consumer Services

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

  1. Stock Market
  2. Insiders
  3. Kirsten Harting
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!